EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE)

Kathryn M Munro; Kirsty J Dixon; Melissa M Gresle; Anna Jonas; Dennis Kemper; William Doherty; Louis J Fabri; Catherine M Owczarek; Martin Pearse; Andrew W Boyd; Trevor J Kilpatrick; Helmut Butzkueven; Ann M Turnley

Journal article

EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE)

Kathryn M Munro, Kirsty J Dixon, Melissa M Gresle, Anna Jonas, Dennis Kemper, William Doherty, Louis J Fabri, Catherine M Owczarek, Martin Pearse, Andrew W Boyd, Trevor J Kilpatrick, Helmut Butzkueven, Ann M Turnley

PLOS ONE | PUBLIC LIBRARY SCIENCE | Published : 2013

DOI: 10.1371/journal.pone.0055948

University of Melbourne Researchers

Trevor Kilpatrick Author Florey Department of Neuroscience and Mental Health

Helmut Butzkueven Author Medicine - Royal Melbourne Hospital

Melissa Gresle Author Medicine - Royal Melbourne Hospital

Kathryn Munro Author Anatomy and Neuroscience

Grants

Awarded by NHMRC

Funding Acknowledgements

This work was supported by a NH&MRC Project Grant #1045125 and a Multiple Sclerosis Research Australia grant. AMT is supported by an NH&MRC Fellowship, HB by an NH&MRC career development fellowship, MG by a CRE fellowship through the Melbourne Brain Centre, and KMM was supported by an NH&MRC Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.